New Delhi: On Monday the committee for Scientific and Industrial Research (CSIR) launched its ayurvedic anti-diabetic drug BGR-34. Intended at organization type 2 diabetes, BGR-34 has been together urbanized by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), together situated in Lucknow. NBRIs’ Senior Principal Scientist A.K.S. Rawat conveyed that, the contemporary diabetes drugs are known for side-effects and toxicity while BGR-34 machinery by managing blood sugar and warning the damaging belongings of additional drugs.
NBRI and CIMAP scientists intentional nearly 500 very old herbs scheduled in ayurvedic texts to nothing in on daruharidra (Berberis aristata), giloy (Tinospora cordifolia), vijaysar (Pterocarpus marsupium), gudmar (Gymnema sylvestre), majeeth (Rubia cordifoila) and methika (Trigonella foenum-graecum) to create the anti-diabetic formulation. Ayurvedic pharma compnay AIMIL Pharmaceuticals will commercially create and deal out BGR- 34, which has been priced at Rs 5 and will be obtainable extensively crossways Karnataka and neighbouring states. ‘BGR-34 is an exclusive manufactured goods that manages the lives of human suffering diabetics. AIMIL Pharmaceuticals vice president Anil Kumar Sharma conveyed that, the thing for consumption approved several batteries of tests and showed hypoglycemic activity in experimental subjects.